Evon Medics
Science Behind COAT™
Breakthrough neuroscience.
Computerized Olfactory Adaptive Training (COAT™) is supported by peer-reviewed clinical research..
Bigger Memory Centers
Grows regions linked to stronger memory and recall
Clinical Trial
Randomized controlled study N = 70 participants
Peer-Reviewed
Published in Alzheimer's & Dementia: TRCI
For Investors
Backing the Next Generation of Brain Health Innovation
EVON Medics is advancing COAT™, a computational” use “novel adaptive intelligence based neuromodulatory system” backed by peer reviewed research and NIH support. Explore our vision and progress for an investment opportunity.
About Dr. Evaristus Nwulia
From Clinical Observation to Transforming Brain Health
What began as a breakthrough scientific idea has grown into a mission to transform neurological care. Discover how Dr. Evaristus Nwulia's journey from physician and neuroscientist to entrepreneur led to the creation of Evon Medics, Inc.
Our latest
Press Coverage
Join us as we bring the future of cognitive health forward
Alzheimer's & Dementia: Translational Research & Clinical Interventions
A randomized, double-blind, sham-controlled feasibility trial in 70 participants with mild cognitive impairment finds COAT's computerized olfactory adaptive training associated with improved Preclinical Alzheimer's Cognitive Composite scores and gray matter volume in medial temporal brain regions.
National Institutes of Health COAT™ Spotlight
Study suggests computerized olfactory stimulation may improve cognition, with implications for Alzheimer's disease. NIH spotlights the NIA-funded trial, noting COAT's home-based device as a step beyond traditional olfactory training.
